Your browser doesn't support javascript.
loading
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Wang, Xiao Qian; Danenberg, Esther; Huang, Chiun-Sheng; Egle, Daniel; Callari, Maurizio; Bermejo, Begoña; Dugo, Matteo; Zamagni, Claudio; Thill, Marc; Anton, Anton; Zambelli, Stefania; Russo, Stefania; Ciruelos, Eva Maria; Greil, Richard; Gyorffy, Balázs; Semiglazov, Vladimir; Colleoni, Marco; Kelly, Catherine M; Mariani, Gabriella; Del Mastro, Lucia; Biasi, Olivia; Seitz, Robert S; Valagussa, Pinuccia; Viale, Giuseppe; Gianni, Luca; Bianchini, Giampaolo; Ali, H Raza.
  • Wang XQ; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Danenberg E; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Huang CS; National Taiwan University Hospital, College of Medicine, National Taiwan University and Taiwan Breast Cancer Consortium, Taipei, Taiwan.
  • Egle D; Department of Gynecology, Brust Gesundheit Zentrum Tirol, Medical University Innsbruck, Innsbruck, Austria.
  • Callari M; Fondazione Michelangelo, Milan, Italy.
  • Bermejo B; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Dugo M; Medicine Department, Universidad de Valencia, Valencia, Spain.
  • Zamagni C; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.
  • Thill M; San Raffaele Hospital, Milan, Italy.
  • Anton A; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.
  • Zambelli S; Department of Gynecology and Gynecological Oncology, Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.
  • Russo S; Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Ciruelos EM; San Raffaele Hospital, Milan, Italy.
  • Greil R; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Gyorffy B; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Semiglazov V; 3rd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Colleoni M; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Kelly CM; Cancer Cluster Salzburg, Salzburg, Austria.
  • Mariani G; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.
  • Del Mastro L; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary.
  • Biasi O; NN Petrov Research Institute of Oncology, St. Petersburg, Russia.
  • Seitz RS; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
  • Valagussa P; Mater Private Hospital, Dublin and Cancer Trials Ireland Breast Group, Dublin, Ireland.
  • Viale G; Fondazione IRCSS - Istituto Nazionale Tumori, Milan, Italy.
  • Gianni L; IRCCS Ospedale Policlinico San Martino, UO Clinica di Oncologia Medica, Genoa, Italy.
  • Bianchini G; Dipartimento di Medicina Interna e Specialità Mediche (Di.M.I.), Università di Genova, Genoa, Italy.
  • Ali HR; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
Nature ; 621(7980): 868-876, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37674077

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Neoplasias de la Mama Triple Negativas / Inmunoterapia Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Neoplasias de la Mama Triple Negativas / Inmunoterapia Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article